Obesity Definitions in Sarcopenic Obesity: Differences in Prevalence, Agreement and Association with Muscle Function
Open accessThe DOI matches its Crossref record; 14 of the 14 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Sarcopenic obesity (SO) is associated with poorer physical performance in the elderly and will increase in relevance with population ageing and the obesity epidemic. The lack of a consensus definition for SO has resulted in variability in its reported prevalence, poor inter-definitional agreement, and disagreement on its impact on physical performance, impeding further development in the field. While sarcopenia definitions have been compared, the impact of obesity definitions in SO has been less well-studied. OBJECTIVES: To compare 3 widely-adopted definitions of obesity in terms of SO prevalence, inter-definitional agreement, and association with muscle function. DESIGN: Cross-sectional. SETTING: GERILABS study, Singapore Participants: 200 community-dwelling, functionally-independent older adults. MEASUREMENTS: We utilized three commonly-used definitions of obesity: body mass index (BMI), waist circumference (WC) and DXA-derived fat mass percentage (FM%). Sarcopenia was defined using Asian Working Group for Sarcopenia criteria. For muscle function, we assessed handgrip strength, gait speed and Short Physical Performance Battery (SPPB). Subjects were classified into 4 body composition phenotypes (normal, obese, sarcopenic and SO), and outcomes were compared between groups. RESULTS: The prevalence rate for SO was lowest for BMI (0.5%) compared to FM% (10.0%) and WC (10.5%). Inter-definitional agreement was lowest between BMI and WC (κ=0.364), and at best moderate between FM% and WC (κ=0.583). SO performed the worst amongst body composition phenotypes in handgrip strength, gait speed and SPPB (all p<0.01) only when defined using WC. In regression analyses, SO was associated with decreased SPPB scores (β=-0.261, p=0.001) only for the WC definition. CONCLUSION: There is large variation in the prevalence of SO across different obesity definitions, with low-to-moderate agreement between them. Our results corroborate recent evidence that WC, and thus central obesity, is best associated with poorer muscle function in SO. Thus, WC should be further explored in defining obesity for accurate and early characterization of SO among older adults in Asian populations.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sarcopenia in Asia: Consensus Report of the Asian Working Group for Sarcopenia
Chen, L.-K., Liu, L.-K., Woo, J., Assantachai, P., Auyeung, T.-W., Bahyah, K. S., Chou, M.-Y., Chen, L.-Y., Hsu, P.-S., Krairit, O., et al. (2014) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.11.025 · Cited by 4,051 · cited 2×
“While published consensus definitions for sarcopenia have emerged in recent years (4, 12, 13), there is a comparative lack of consensus regarding obesity definitions in the context of SO, leading to great variation in the methods and cut-offs being applied to define obesity (14).”
Fielding, R. A., Vellas, B., Evans, W. J., Bhasin, S., Morley, J. E., Newman, A. B., Abellan van Kan, G., Andrieu, S., Bauer, J., Breuille, D., et al. (2011) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2011.01.003 · Cited by 3,256 · cited 1×
“While published consensus definitions for sarcopenia have emerged in recent years (4, 12, 13), there is a comparative lack of consensus regarding obesity definitions in the context of SO, leading to great variation in the methods and cut-offs being applied to define obesity (14).”
Studenski, S. A., Peters, K. W., Alley, D. E., Cawthon, P. M., McLean, R. R., Harris, T. B., Ferrucci, L., Guralnik, J. M., Fragala, M. S., Kenny, A. M., et al. (2014) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glu010 · Cited by 2,545 · cited 1×
“While published consensus definitions for sarcopenia have emerged in recent years (4, 12, 13), there is a comparative lack of consensus regarding obesity definitions in the context of SO, leading to great variation in the methods and cut-offs being applied to define obesity (14).”
Garvey, W. T., Mechanick, J. I., Brett, E. M., Garber, A. J., Hurley, D. L., Jastreboff, A. M., Nadolsky, K., Pessah-Pollack, R., & Plodkowski, R. (2016) · Endocrine Practice · doi:10.4158/ep161365.gl · Cited by 1,914 · cited 1×
“%) measures total body fat but not its distribution (15).”
Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies
Batsis, J. A., & Villareal, D. T. (2018) · Nature Reviews Endocrinology · doi:10.1038/s41574-018-0062-9 · Cited by 1,382 · cited 3×
“The resultant synergistic complications from both sarcopenia and obesity lead to worse outcomes in SO than either condition alone, resulting in negative health impacts such as loss of independence, disability, reduced quality of life and increased mortality (9-11).”
SARC-F: A simple questionnaire to rapidly diagnose sarcopenia
Malmstrom, T. K., & Morley, J. E. (2013) · Journal of the American Medical Directors Association · doi:10.1016/j.jamda.2013.05.018 · Cited by 1,319 · cited 1×
“Evaluating geriatric syndromes included screening for muscle symptoms using the SARC-F questionnaire (25), frailty using the FRAIL questionnaire (26), cognitive function via the locally-validated CMMSE (17), depressive symptoms using the 15-item Geriatric Depression Scale (GDS-15) (27) and…”
Body Composition in Healthy Aging
BAUMGARTNER, R. N. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb06498.x · Cited by 1,078 · cited 1×
“The resultant synergistic complications from both sarcopenia and obesity lead to worse outcomes in SO than either condition alone, resulting in negative health impacts such as loss of independence, disability, reduced quality of life and increased mortality (9-11).”
Sarcopenic Obesity Predicts Instrumental Activities of Daily Living Disability in the Elderly
Baumgartner, R. N., Wayne, S. J., Waters, D. L., Janssen, I., Gallagher, D., & Morley, J. E. (2004) · Obesity Research · doi:10.1038/oby.2004.250 · Cited by 937
Kalinkovich, A., & Livshits, G. (2017) · Ageing Research Reviews · doi:10.1016/j.arr.2016.09.008 · Cited by 882 · cited 3×
“IMAT has been linked with adipose tissue inflammation due to the secretion of cytokines such as monocyte chemoattractant protein-1, and the resultant proinflammatory milieu and accelerated muscle catabolism can then lead to decreased muscle mass and impaired strength (34).”
Sarcopenic Obesity: The Confluence of Two Epidemics
Roubenoff, R. (2004) · Obesity Research · doi:10.1038/oby.2004.107 · Cited by 453 · cited 1×
“Body composition changes that occur with aging can lead to sarcopenic obesity (SO), an emerging worldwide phenomenon that has been described as the confluence of two public health crises, namely the obesity epidemic and population aging (1, 2).”
Muscle loss and obesity: the health implications of sarcopenia and sarcopenic obesity
Wannamethee, S. G., & Atkins, J. L. (2015) · Proceedings of the Nutrition Society · doi:10.1017/s002966511500169x · Cited by 404
Batsis, J. A., Barre, L. K., Mackenzie, T. A., Pratt, S. I., Lopez‐Jimenez, F., & Bartels, S. J. (2013) · Journal of the American Geriatrics Society · doi:10.1111/jgs.12260 · Cited by 330 · cited 2×
“For instance, the prevalence of SO in older adults was reported to differ by up to 26 times when various definitions are applied to the same study population (7).”
InfluentialKemmler, W., von Stengel, S., Engelke, K., Sieber, C., & Freiberger, E. (2016) · Osteoporosis International · doi:10.1007/s00198-015-3303-y · Cited by 47 · cited 1×
“Unsurprisingly, there is increasing attention on SO, a high-risk geriatric syndrome that is predominantly observed in an ageing population and has reported prevalence rates ranging from 0.9% to 30.1% (6, 7).”
InfluentialMonocyte chemoattractant protein-1: a proinflammatory cytokine elevated in sarcopenic obesity
Chong, M. S., Lim, J. P., Leung, B., Ding, Y. Y., Tay, L., Ismail, N. H., Yeo, A., & Yew, S. (2015) · Clinical Interventions in Aging · doi:10.2147/cia.s78901 · Cited by 43 · cited 1×
“IMAT has been linked with adipose tissue inflammation due to the secretion of cytokines such as monocyte chemoattractant protein-1, and the resultant proinflammatory milieu and accelerated muscle catabolism can then lead to decreased muscle mass and impaired strength (34).”
Self-citation
Cited by
Hassapidou, M., Vlassopoulos, A., Kalliostra, M., Govers, E., Mulrooney, H., Ells, L., Salas, X. R., Muscogiuri, G., Darleska, T. H., Busetto, L., et al. (2023) · Obesity Facts · doi:10.1159/000528083 · Cited by 121
Purcell, S. A., Mackenzie, M., Barbosa-Silva, T. G., Dionne, I. J., Ghosh, S., Siervo, M., Ye, M., & Prado, C. M. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2020.583825 · Cited by 48
“Two publications (Zoico et al., 2004; Kim et al., 2009) calculated skeletal muscle percent as: (1.13 x ASM)− ( 0.02 x age ) + (0.61 x sex)+ 0.97 Body weight × 100 where ASM and body weight are in kilograms, age is in years and sex = 0 for female and 1 for male (Kim et al., 2002).”
MethodInfluentialPeng, T.-C., Chen, W.-L., Chen, Y.-Y., Chao, Y.-P., Wu, L.-W., & Kao, T.-W. (2021) · British Journal of Nutrition · doi:10.1017/s0007114521001288 · Cited by 35
Linking epidemiology and molecular mechanisms in sarcopenic obesity in populations
El Bizri, I., & Batsis, J. A. (2020) · Proceedings of the Nutrition Society · doi:10.1017/s0029665120000075 · Cited by 23
Lee, S., Lim, J., Tan, C., Yeo, A., Chew, J., & Lim, W. (2024) · Geriatrics & Gerontology International · doi:10.1111/ggi.14758 · Cited by 12
Self-citation
Metadata
- Authors
- Khor, E. Q.-E., Lim, J. P., Tay, L., Yeo, A., Yew, S., Ding, Y. Y., & Lim, W. S.
- Venue
- The Journal of Frailty & Aging
- Publisher
- Elsevier BV
- Published
- 2020-01
- Volume
- 9
- Issue
- 1
- Pages
- 37-43
- ISSN
- 2260-1341 (ISSN-L)
- OpenAlex
- W2969059001
- Cited by
- 48
- References
- 14
- FWCI
- 3.52
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.